Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial "OCEAN"
Recruiting
Phase 4 Results N/ASummary of Purpose
This trial is comparing medical approaches for stroke prevention in people who have atrial fibrillation (AF) and have undergone a successful procedure called ablation to eliminate or substantially reduce the arrhythmia. AF is normally associated with an increased risk of stroke which in many patients can be prevented with appropriate blood thinner therapy. This trial will compare a strategy of oral anticoagulant...
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 11 April 2018.
1 Jan 2016 | 18 Jun 2014 | 1 Sep 2021 | 1 Dec 2021 | 1 Apr 2018 | Unavailable |
Start Date | First Received | 1st Completion | Completion | Verification | Results |
---|
Trial Design
- Allocation: Randomized
- Masking: Open Label
- Purpose: Prevention
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
Contacts
- David H Birnie, MD
- Karen MacDonald, RN
kmacdonald@ottawaheart.ca 613-798-5555
- Sonya Jancar, RN BScN, M(HLM)
ocean@ottawaheart.ca 613-696-7000
View Trial Locations
Recruitment
- Enrollment: 1,572
- Gender: All
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 21 locations, 2 countries
Principal Investigators
- Atul Verma, MD
atul.verma@utoronto.ca 905-895-4521
- David H Birnie, MD
University of Ottawa Heart Institute